跳至主要内容
临床试验/NCT00912990
NCT00912990终止不适用

Pediatric Elective Intubation With and Without Muscle Relaxation Utilizing the Shikani Optical Stylet

Rady Children's Hospital, San Diego1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2007年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
34
试验地点
1
主要终点
Time to Intubation

研究概览

简要总结

The investigators' primary specific aims are to demonstrate that:

  1. Pediatric patients with normal airways, undergoing elective surgical procedures, can be successfully intubated when deeply sedated, without the use of muscle relaxants using the Shikani Optical Stylet.
  2. Shikani intubation of pediatric patients is equally effective in children that are deeply sedated or paralyzed as evidenced by a non-significant difference in:
  • Time to intubation (defined as no more than a 30 second time difference between the two groups);
  • Incidence of adverse events.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
6 Months 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 6 months of age to 17 years of age (not yet 18)
  • Male or female
  • English or Spanish speaking
  • Normal airway (Mallampati Classification )
  • American Society of Anesthesiology Physical Status Classification I or II
  • Elective surgical procedure expected to last at least 45 minutes in length
  • Written informed consent/assent for participation given by the parent legal guardian and subject (if applicable)

排除标准

  • < 6 months of age, > 17 years of age
  • Difficult airway (Mallampati Classification)
  • History of previous difficult intubation, suspected abnormal airway: *micrognathia
  • facial trauma
  • airway tumor
  • epiglottitis
  • retropharyngeal abscess
  • foreign body, etc.
  • Scheduled for non-elective, emergent OR procedure
  • Parent, legal guardian, or subject is unavailable or unwilling to consent for study participation

研究组 & 干预措施

Normal saline

Placebo Comparator

Normal saline volume calculated to be equal to the volume of cisatracurium 0.2mg/kg

干预措施: Normal saline (Drug)

Cisatracurium

Active Comparator

Subjects in this arm will be given Cisatracurium 0.2mg/kg IV dose one time prior to intubation.

干预措施: Cisatracurium (Drug)

结局指标

主要结局

Time to Intubation

时间窗: Confirmed by the visualization of three carbon dioxide waveforms.

Time to intubation was defined as the time (seconds) required to verify three breaths on an end-tidal carbon dioxide monitor.

次要结局

  • The Number of Adverse Events(Recorded from the start of the intubation procedure to the time of successful endotracheal intubation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sandeep Khanna

Attending Physician Division of Pediatric Critical Care

Rady Children's Hospital, San Diego

研究点 (1)

Loading locations...

相似试验